More obesity experts support the demand for a blue prescription for Wegovy. A push from the manufacturer means that Norwegian authorities must decide.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.